Clinical trials
Phase 1 Small Cell Lung Carcinoma trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 5 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
| Completed | 8 |
| Active, not recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 3 |
| Amgen | 3 |
| BeiGene | 2 |
| MacroGenics | 2 |
| AstraZeneca | 1 |
| Bristol-Myers Squibb | 1 |
| GlaxoSmithKline | 1 |
| Huahui Health | 1 |
| Incyte Corporation | 1 |
| Innovent Biologics (Suzhou) Co. Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Small Cell Lung Carcinoma | 20 |
| Carcinoma, Non-Small-Cell Lung | 10 |
| Ovarian Neoplasms | 8 |
| Triple Negative Breast Neoplasms | 8 |
| Endometrial Neoplasms | 6 |
| Neoplasms | 6 |
| Uterine Cervical Neoplasms | 6 |
| Breast Neoplasms | 5 |
| Carcinoma, Hepatocellular | 5 |
| Squamous Cell Carcinoma of Head and Neck | 5 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.